Biotech News

Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update

Novan (NOVN)Novan2023-05-15 06:45 ESTEarnings

- Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% (SB206) -

- Strong prescription growth across three promoted products -

- Company to host conference call today at 8:30 a.m. ET -

DURHAM, N.C., May 15,...

Novan

Novan was a dermatology-focused biotechnology company built around nitric oxide-based therapies for skin conditions and related inflammatory indications. Its story was centered on a narrow clinical platform and the challenge of turning topical science into a durable commercial path.

Recent company news

NOVNNovan2023-07-17 08:45 EST

Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection

NOVNNovan2023-06-05 09:00 EST

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

NOVNNovan2023-05-31 16:05 EST

Novan Focuses Strategic Direction and Announces Restructuring

NOVNNovan2023-05-15 06:45 EST